Olanzapine in Patients With Advanced Cancer and Weight Loss
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to find the highest tolerable dose of the drug
Olanzapine that can be given to patients with advanced cancer who are experiencing weight
loss. Researchers want to find out if Olanzapine can help decrease weight loss in patients
who are experiencing it because of cancer. How this drug affects performance status,
cancer-related symptoms, and nutritional status in patients with advanced cancer will also be
studied.